Correlation Between Unicycive Therapeutics and Erytech Pharma

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Erytech Pharma SA, you can compare the effects of market volatilities on Unicycive Therapeutics and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Erytech Pharma.

Diversification Opportunities for Unicycive Therapeutics and Erytech Pharma

-0.29

Correlation Coefficient

Unicycive Therapeutics  Erytech Pharma

Very good diversification

The 3 months correlation between Unicycive and Erytech is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Erytech Pharma go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Erytech Pharma

If you would invest  89.00  in Unicycive Therapeutics on October 9, 2024 and sell it today you would lose (11.00) from holding Unicycive Therapeutics or give up 12.36% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.4%
Values	Daily Returns

Unicycive Therapeutics  vs.  Erytech Pharma SA

Unicycive Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Erytech Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Erytech Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Erytech Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Unicycive Therapeutics and Erytech Pharma

The main advantage of trading using opposite Unicycive Therapeutics and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.

The idea behind Unicycive Therapeutics and Erytech Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.